Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
People with Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Exhibit Similarly Impaired Vascular
Marie Mclaughlin1, Nilihan E M Sanal-Hayes2, Lawrence D Hayes3
1Sport and Physical Activity Research Institute, School of Health and Life Sciences, University of the West of Scotland, Glasgow, United Kingdom; School of Sport, Exercise & Rehabilitation Sciences, Faculty of Health Sciences, University of Hull, United Kingdom.
Insights
Individuals with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) show similar impaired endothelial function. This suggests vascular involvement and increased cardiovascular risk in both post-viral conditions.
Area of Science:
- Cardiovascular Research
- Post-Viral Syndromes
- Endothelial Function
Background:
- Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are complex post-viral conditions with overlapping symptoms.
- Understanding the underlying pathophysiology, particularly vascular involvement, is crucial for effective clinical management and improving long-term health outcomes.
Purpose of the Study:
- To compare flow-mediated dilation (FMD) in individuals with long COVID, ME/CFS, and healthy controls.
- To assess potential vascular dysfunction and its implications for these patient groups.
Main Methods:
- A case-case-control study involving 51 participants (17 long COVID, 17 ME/CFS, 17 healthy controls).
- Flow-mediated dilation (FMD) measurements of brachial artery diameter were obtained and analyzed using 1-way ANOVA.
Main Results:
- Both long COVID and ME/CFS groups exhibited significantly impaired endothelial function compared to healthy controls (FMD values: 6.99% and 6.60% vs 11.30%, P < .05).
- No significant difference in FMD was observed between long COVID and ME/CFS groups (P = .949).
- ME/CFS patients had a significantly longer illness duration (16 years) than long COVID patients (1.36 years) (P < .0001).
Conclusions:
- Long COVID and ME/CFS share similarly impaired endothelial function, suggesting common vascular mechanisms in post-viral syndromes.
- Reduced FMD indicates potential increased cardiovascular risk, necessitating monitoring and targeted interventions for endothelial health.
Background:
This study aimed to compare flow-mediated dilation values between individuals with long COVID, individuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and healthy age-matched controls to assess the potential implications for clinical management and long-term health outcomes.
Methods:
A case-case-control approach was employed, and flow-mediated dilation measurements were obtained from 51 participants (17 long COVID patients, 17 ME/CFS patients, and 17 healthy age-matched controls). Flow-mediated dilation values were analyzed using 1-way analysis of variance for between-group comparisons.
Results:
Results revealed significantly impaired endothelial function in both long COVID and ME/CFS groups compared with healthy age-matched controls as determined by maximum % brachial artery diameter post-occlusion compared with pre-occlusion resting diameter (6.99 ± 4.33% and 6.60 ± 3.48% vs 11.30 ± 4.44%, respectively, both P < .05). Notably, there was no difference in flow-mediated dilation between long COVID and ME/CFS groups (P = .949), despite significantly longer illness duration in the ME/CFS group (ME/CFS: 16 ± 11.15 years vs long COVID: 1.36 ± 0.51 years, P < .0001).
Conclusion:
The study demonstrates that both long COVID and ME/CFS patients exhibit similarly impaired endothelial function, indicating potential vascular involvement in the pathogenesis of these post-viral illnesses. The significant reduction in flow-mediated dilation values suggests an increased cardiovascular risk in these populations, warranting careful monitoring and the development of targeted interventions to improve endothelial function and mitigate long-term health implications.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy IV: Restrictive Cardiomyopathy

